市場調查報告書

血液透析機的全球市場:成長,趨勢,及預測

Hemodialysis Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 921279
出版日期 內容資訊 英文 112 Pages
商品交期: 2-3個工作天內
價格
血液透析機的全球市場:成長,趨勢,及預測 Hemodialysis Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 112 Pages
簡介

全球血液透析機市場的主要成長要素,是末期腎臟疾病(ESRD)患者數的增加,和糖尿病和高血壓的發生率增加。ESRD數的增加和移植的腎臟不足,預計推動該市場的成長。慢性腎臟病(CKD),是經過一定期間引起腎功能低的狀態。也有經過幾年發病成為ESRD的可能性,成為持續增大的公共衛生問題。由於腎功能衰竭的負擔高漲對血液透析機設備有龐大的需求,導致該市場大幅度成長。

本報告提供全球血液透析機市場的相關調查,市場機會和趨勢,成長及阻礙因素,各產品類型、模式、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 市場成長要素
    • 末期腎臟疾病患者的增加
    • 糖尿病和高血壓的發生率增加
  • 阻礙市場要素
    • 透析伴隨的風險與併發症
  • 波特的五力分析

第5章 市場區隔

  • 各產品類型
    • 設備
    • 消耗品
  • 各種模式
    • 傳統的長期血液透析機
    • 短時間血液透析機(每天)
    • 夜間血液透析機
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • 旭化成株式會社
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton, Dickinson and Company
    • Cantel Medical Corp.
    • DaVita Inc.
    • Fresenius Medical Care AG & Co. KGaA
    • Medtronic PLC
    • Nipro Corporation
    • NxStage Medical, Inc.

第7章 市場機會及今後趨勢

目錄
Product Code: 67144

Market Overview

The major factors for the growth of the hemodialysis market include the rising number of end-stage renal disease (ESRD) patients and the increasing incidence of diabetes and hypertension.

The rise in the number of ESRD and shortage in the availability of kidneys for transplant expected to boost the growth of the market. Chronic kidney disease (CKD) is a condition that causes reduced kidney function over a period of time. It may develop over many years and lead to end-stage kidney (or renal) disease (ESRD). It has become an enormous public health issue that continues to rise. As per the estimation by the Global Burden of Disease Study, kidney disease was the 12th-most common cause of death, accounting for 1.1 million deaths worldwide in 2015. Furthermore, as per the 2016 report on Diabetes and Chronic Kidney Disease, diabetes causes 44% of all new cases of kidney failure. Thus, owing to the rising burden of kidney failures there will be a huge demand for hemodialysis equipment resulting in high growth of the market.

Scope of the Report

As per the scope of this report, hemodialysis is a process of purifying the blood of a person whose kidneys are not working normally. The market covers various equipment and consumables that are used for hemodialysis. The market is segmented by product type, modality, and geography.

Key Market Trends

Conventional Long-Term Hemodialysis is the Segment by Modality expected to Hold Largest Market Share over the Forecast Period

The hemodialysis market is segmented by Modality in three major segments Conventional Long-Term Hemodialysis, Short Daily Hemodialysis, and Nocturnal hemodialysis. The Conventional Long-Term Hemodialysis is expected to hold a large market share owing to the huge acceptance of hemodialysis therapy over peritoneal dialysis among CKD and ESRD patients. According to the Organ Procurement and Transplantation Network around 83.7% of people are waiting for kidney transplants. Thus, owing to the shortage of kidneys for transplant the market is expected to witness high growth.

North America is Expected to Hold Largest Market Share over the Forecast Period

The United States is expected to be the largest market for hemodialysis owing to the presence of better healthcare infrastructure and the presence of major market players. As per the National Institute of Diabetes and Digestive and Kidney Disease, the prevalence of Chronic Kidney Disease (CKD) in the United States is about 14%. The prevalence of CKD is approximately 32% in the population above age 60 years, which occupies more than 15% of the US population. Also, there are currently 121,678 people waiting for lifesaving organ transplants in the United States of these, 100,791 await kidney transplants. Thus, considering all the above-mentioned factors the market is expected to witness high growth.

Competitive Landscape

The market studied is a moderately consolidated market owing to the presence of a few market players. Some of the market players are Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Cantel Medical Corp., DaVita Inc., Fresenius Medical Care AG & Co. KGaA, Medtronic PLC, Nipro Corporation, and NxStage Medical, Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Number of End Stage Renal Disease Patients
    • 4.2.2 Increasing Incidence of Diabetes and Hypertension
  • 4.3 Market Restraints
    • 4.3.1 Risks and Complications associated with Dialysis
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Equipment
      • 5.1.1.1 Dialysis Machines
      • 5.1.1.2 Hemodialysis Water Treatment Systems
      • 5.1.1.3 Others hemodialysis equipment
    • 5.1.2 Consumables
      • 5.1.2.1 Dialyzers
      • 5.1.2.2 Catheters
      • 5.1.2.3 Other hemodialysis consumables
  • 5.2 By Modality
    • 5.2.1 Conventional Long-Term Hemodialysis
    • 5.2.2 Short Daily Hemodialysis
    • 5.2.3 Nocturnal hemodialysis
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Asahi Kasei Corporation
    • 6.1.2 B. Braun Melsungen AG
    • 6.1.3 Baxter International Inc.
    • 6.1.4 Becton, Dickinson and Company
    • 6.1.5 Cantel Medical Corp.
    • 6.1.6 DaVita Inc.
    • 6.1.7 Fresenius Medical Care AG & Co. KGaA
    • 6.1.8 Medtronic PLC
    • 6.1.9 Nipro Corporation
    • 6.1.10 NxStage Medical, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS